Published May 2021 | Version v1
Journal article Metadata-only

Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer

Creators

  • 1. Department of Radiation Oncology, David Geffen School of Medicine at UCLA, Los Angeles (United States)
  • 2. Department of Radiation Oncology, Stanford University, Stanford (United States)
  • 3. Department of Radiation Oncology, University Hospitals Case Medical Center, Cleveland (United States)
  • 4. Department of Radiation Oncology, Vanderbilt University School of Medicine, Nashville (United States)
  • 5. Department of Radiation Oncology, University of Michigan School of Medicine, Ann Arbor (United States)

Description

Numerous dose and fractionation schedules have been used to treat medically inoperable stage I non-small cell lung cancer (NSCLC) with stereotactic body radiation therapy (SBRT) or stereotactic ablative radiation therapy. We evaluated published experiences with SBRT to determine local control (LC) rates as a function of SBRT dose.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.ijrobp.2019.03.045

Additional details

Identifiers

DOI
10.1016/j.ijrobp.2019.03.045;
PII
S0360301619305723;

Publishing Information

Journal Title
International Journal of Radiation Oncology, Biology and Physics
Journal Volume
110
Journal Issue
1
Journal Page Range
p. 160-171
ISSN
0360-3016
CODEN
IOBPD3

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
53124504
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
FRACTIONATED IRRADIATION; FRACTIONATION; LUNGS; NEOPLASMS; RADIATION DOSES; RADIOTHERAPY
Descriptors DEC
BODY; DISEASES; DOSES; IRRADIATION; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; RESPIRATORY SYSTEM; SEPARATION PROCESSES; THERAPY

Optional Information

Copyright
Copyright (c) 2019 Elsevier Inc. All rights reserved.